Xalatan and Alphagan p drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Xalatan and Alphagan p together. This review analyzes the effectiveness and drug interactions between Xalatan and Alphagan p. It is created by eHealthMe based on reports of 1,968 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Xalatan and Alphagan p, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Xalatan and Alphagan p

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Xalatan

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. (latest outcomes from Xalatan 19,189 users)

Alphagan P

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. (latest outcomes from Alphagan p 2,035 users)

On Feb, 22, 2017

1,968 people who take Xalatan, Alphagan P are studied.


Number of reports submitted per year:

Xalatan and Alphagan p drug interactions.

Most common drug interactions over time *:

< 1 month:
  • vision blurred
  • eye irritation
  • eye pain
  • drug ineffective
  • ocular hyperaemia
  • anxiety
  • dizziness
  • eyelid oedema
  • hypersensitivity
  • macular degeneration
1 - 6 months:
  • pancytopenia
  • pyrexia
  • bone marrow failure
  • inflammation
  • cough
  • tonsillitis
  • dyspnoea
  • nasal congestion
  • abnormal dreams
  • eye irritation
6 - 12 months:
  • cough
  • neutropenia
  • thrombocytopenia
  • dyspnoea
  • nasal congestion
  • abnormal dreams
  • blood alkaline phosphatase increased
  • blood creatinine increased
  • general physical health deterioration
  • herpes zoster
1 - 2 years:
  • nasal congestion
  • cough
  • dyspnoea
  • intraocular pressure increased
  • pain
  • abnormal dreams
  • growth of eyelashes
  • tinnitus
  • drug ineffective
  • ocular hyperaemia
2 - 5 years:
  • eye irritation
  • ocular hyperaemia
  • depression
  • drug hypersensitivity
  • eye disorder
  • intraocular pressure increased
  • abnormal dreams
  • amnesia
  • arrhythmia
  • cataract
5 - 10 years:
  • bradycardia
  • malaise
  • cataract
  • drug ineffective
  • cardiac disorder
  • dizziness
  • dyspnoea
  • gastrointestinal haemorrhage
  • intraocular pressure increased
  • arteriosclerosis
10+ years:
  • asthenia
  • blepharitis
  • blister
  • corneal disorder
  • eye colour change
  • eye irritation
  • eyelash discolouration
  • eyelid cyst
  • muscular weakness
  • nausea
not specified:
  • intraocular pressure increased
  • drug ineffective
  • glaucoma
  • dyspnoea
  • visual acuity reduced
  • eye irritation
  • fatigue
  • pain
  • dizziness
  • fall

Most common drug interactions by gender *:

female:
  • drug ineffective
  • dyspnoea
  • visual acuity reduced
  • fatigue
  • intraocular pressure increased
  • glaucoma
  • pain
  • eye irritation
  • asthenia
  • dizziness
male:
  • intraocular pressure increased
  • glaucoma
  • eye irritation
  • drug ineffective
  • visual acuity reduced
  • dyspnoea
  • ocular hyperaemia
  • pain
  • cardiac failure congestive
  • eye pain

Most common drug interactions by age *:

0-1:
  • apnoea
  • bradycardia neonatal
  • cyanosis neonatal
  • depressed level of consciousness
  • developmental delay
  • feeding problem in newborn
  • hypotension
  • hypothermia
  • hypotonia neonatal
  • iris disorder
2-9:
  • injection site pain
10-19:
  • antibody test abnormal
  • coombs test positive
  • haemoglobin decreased
  • immunodeficiency
20-29:
  • drug ineffective
  • vitreous haemorrhage
  • corneal oedema
  • intraocular pressure increased
  • vision blurred
  • blood pressure decreased
  • dyspnoea
  • feeling abnormal
  • hypertension
  • retinal tear
30-39:
  • blood alkaline phosphatase increased
  • blood creatinine increased
  • general physical health deterioration
  • herpes zoster
  • neutropenia
  • pneumonia
  • pubis fracture
  • renal impairment
  • sepsis
  • thrombocytopenia
40-49:
  • intraocular pressure increased
  • ocular hyperaemia
  • eye irritation
  • eye pain
  • visual acuity reduced
  • blindness unilateral
  • cataract
  • corneal infection
  • drug ineffective
  • gastrointestinal haemorrhage
50-59:
  • dyspnoea
  • pain
  • glaucoma
  • visual acuity reduced
  • pneumonia
  • fall
  • nausea
  • vomiting
  • anaemia
  • contusion
60+:
  • intraocular pressure increased
  • drug ineffective
  • eye irritation
  • visual acuity reduced
  • fatigue
  • glaucoma
  • asthenia
  • vision blurred
  • dizziness
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Xalatan and Alphagan p?

Interactions between Xalatan and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Alphagan p and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Xalatan (latanoprost) is often used to treat glaucoma. Alphagan p (brimonidine tartrate) is often used to treat glaucoma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

You may be interested in these reviews

More reviews for: Xalatan, Alphagan p